Company
SATO Pharmaceutical Co., Ltd.
SATO Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| SKX-16 (Luliconazole 10% Solution) | Phase 2 | Onychomycosis of Toenails |
Latest
No recent events.
Follow SATO Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.